Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.

Corticosteroid or 5-aminosalicylic acid enemas are the treatment of choice for distal ulcerative colitis but up to one third of patients may be unresponsive. As an alternative therapy might be advantageous, the efficacy of six weeks' treatment with 2 g 4-aminosalicylic acid (4-ASA) (n = 24) and...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	O'Donnell, L, Arvind, A, Hoang, P, Cameron, D, Talbot, I, Jewell, D, Lennard-Jones, J, Farthing, M
Format:	Journal article
Język:	English
Wydane:	BMJ Publishing Group 1992

Podobne zapisy

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
od: MG Robinson, i wsp.
Wydane: (1990-01-01)

5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
od: Lloyd R Sutherland, i wsp.
Wydane: (1987-01-01)

A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.
od: Lee, F, i wsp.
Wydane: (1996)

Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.
od: Winter, T, i wsp.
Wydane: (1993)

Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.
od: Selby, W, i wsp.
Wydane: (1984)

Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
od: M Campieri, i wsp.
Wydane: (1990-01-01)

Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
od: Zimmerman, M, i wsp.
Wydane: (1996)

Budesonide Enemas for Topical Therapy of Ulcerative Colitis
od: P Rutgeerts
Wydane: (1990-01-01)

Exacerbation of Ulcerative Colitis following Administration of 5-ASA Enemas
od: Barbara A. Young, i wsp.
Wydane: (1989-01-01)

Perimyocarditis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid
od: Hye Young Lee, i wsp.
Wydane: (2024-05-01)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
od: Hugh James Freeman
Wydane: (2012-01-01)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
od: Hugh James Freeman
Wydane: (2012-10-01)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
od: Long He, i wsp.
Wydane: (2021-05-01)

Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications
od: James M. Richter, i wsp.
Wydane: (2016-01-01)

Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
od: M. Campieri, i wsp.
Wydane: (1989-01-01)

Oral fluticasone propionate in active distal ulcerative colitis.
od: Angus, P, i wsp.
Wydane: (1992)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
od: M. V. Shapina, i wsp.
Wydane: (2017-11-01)

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
od: Hyo Yeop Song, i wsp.
Wydane: (2022-01-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
od: Yan Yan, i wsp.
Wydane: (2019-12-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
od: Jun Xu, i wsp.
Wydane: (2018-06-01)

A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis
od: LR Sutherland, i wsp.
Wydane: (1990-01-01)

Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance
od: Hiroshi Matsumoto, i wsp.
Wydane: (2024-09-01)

Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
od: Lloyd R Sutherland
Wydane: (1993-01-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
od: Soo-Kyung Park, i wsp.
Wydane: (2022-09-01)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
od: Jin Lee, i wsp.
Wydane: (2019-01-01)

Ulcerative colitis.
od: Jewell, D
Wydane: (1975)

Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease.
od: Samarasekera, D, i wsp.
Wydane: (1996)

5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis.
od: Li-Na Zhao, i wsp.
Wydane: (2014-01-01)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
od: Kazuhiko Uchiyama, i wsp.
Wydane: (2023-08-01)

Aetiopathogenesis of ulcerative colitis.
od: Jewell, D
Wydane: (1987)

A systematic review of the efficacy of traditional Chinese medicine retention enema in the treatment of ulcerative colitis
od: Jiaji Li, i wsp.
Wydane: (2024-01-01)

Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema
od: Dong K, i wsp.
Wydane: (2023-01-01)

Azathioprine in ulcerative colitis.
od: Jewell, D, i wsp.
Wydane: (1972)

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
od: Asuka Watanabe, i wsp.
Wydane: (2024-01-01)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
od: Yong Jiang, i wsp.
Wydane: (2016-03-01)

Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis
od: Yan Chen, i wsp.
Wydane: (2022-11-01)

Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.
od: Juan Suárez, i wsp.
Wydane: (2012-01-01)

Therapeutic efficacy of the combination therapy of corticosteroids and 5-aminosalicylic acid for treatment of pyoderma gangrenosum with ulcerative colitis
od: Wei Chen, i wsp.
Wydane: (2020-01-01)

Evaluation of sucralfate enema in experimental diversion colitis
od: José Aires Pereira, i wsp.
Wydane: (2013-10-01)

Infliximab for ulcerative colitis.
od: Simmons, J, i wsp.
Wydane: (2002)